PharmaShots | Incisive News in 3 Shots

Subscribe Now

Caris Life Sciences

Caris Life Sciences Entered into a Multi-Year Strategic Option and License Agreement with Xencor for Novel XmAb Bispecific Antibodies to Treat Cancer

Caris Life Sciences Entered into a Multi-Year Strategic Option and License Agreement with Xencor for Novel XmAb Bispecific Antibod...

August 2, 2022

PharmaShots Interview: In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liquid Biopsy Laboratory Facility

PharmaShots Interview: In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liq...

July 4, 2022

PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Based MI FOLFOXai Predictor

PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Based MI FOLFOXai Predictor

July 27, 2021

PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Powered Clinico-Genomic Data Platform

PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Powered Clinico-Genomic Data Platform

December 1, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us